During the past decade, Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Takeda" with 4 trials sponsored, "BeiGene" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Astex Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" #1 collaborator was "Pharmacyclics LLC." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Legend Biotech" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" are "Multiple Myeloma" (8 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Amyloidosis" (2 trials), "Primary Myelofibrosis (PMF)" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" are "Drug" (18 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (3 trials), "Daratumumab" (3 trials), "Dexamethasone" (3 trials), "Ibrutinib" (3 trials) and "Ixazomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich". undefined are not yet recruiting, 1 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 8 completed trials in Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich has several departments that took part in Clinical trials: "Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych" - 2 trials